Related references
Note: Only part of the references are listed.Psychosocial impact of hidradenitis suppurativa: a practical guide for clinicians
Maximillian A. Weigelt et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
New insights into hidradenitis suppurativa diagnosis via salivary infrared biosignatures: A pilot study
Stephane Derruau et al.
JOURNAL OF BIOPHOTONICS (2021)
Long-standing refractory hidradenitis suppurativa responded to a brodalumab monotherapy in a patient with psoriasis: A possible involvement of Th17 across the spectrum of both diseases
Yasuyuki Yoshida et al.
JOURNAL OF DERMATOLOGY (2021)
Effectiveness of Secukinumab in the treatment of moderate-severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting
S. Ribero et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Tildrakizumab as a potential long-term therapeutic agent for severe Hidradenitis Suppurativa: A 15 months experience of an Australian institution
Yonatan Kok et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2021)
Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa
Y. Cao et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
mTORC1-a potential player in the pathogenesis of hidradenitis suppurativa?
A. Dmitriev et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Target molecules for future hidradenitis suppurativa treatment
Christos C. Zouboulis et al.
EXPERIMENTAL DERMATOLOGY (2021)
The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis
Trinidad Montero-Vilchez et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Quality of Life in Hidradenitis Suppurativa: An Update
Pavel Chernyshov et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Rapid Response to Certolizumab Pegol in Hidradenitis Suppurativa: A Case Report
Pelin Esme et al.
SKIN APPENDAGE DISORDERS (2021)
Tildrakizumab as a potential long-term therapeutic agent for severe Hidradenitis Suppurativa: A 15 months experience of an Australian institution
Yonatan Kok et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2021)
Current and future treatment of hidradenitis suppurativa
K. R. van Straalen et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Lessons learned from the development of a hidradenitis suppurativa xenograft mouse model
Q. Q. Quartey et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2020)
Weight Loss and Dietary Interventions for Hidradenitis Suppurativa: A Systematic Review
Arunima Sivanand et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2020)
Loss of Skin Microbial Diversity and Alteration of Bacterial Metabolic Function in Hidradenitis Suppurativa
Andrea M. Schneider et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Skin Microbiota Perturbations Are Distinct and Disease Severity-Dependent in Hidradenitis Suppurativa
Haley B. Naik et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials
J. S. Kirby et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Dietary and metabolic factors in the pathogenesis of hidradenitis suppurativa: a systematic review
Franchesca Choi et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2020)
Hidradenitis suppurativa and smoking: A systematic review and meta-analysis
Prakash Acharya et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Lesional Inflammatory Profile in Hidradenitis Is Not Driven IL-1
Allard R. J. V. Vossen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Defining hidradenitis suppurativa phenotypes based on the elementary lesion pattern: results of a prospective study
A. Martorell et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Keratin 5-Cre-driven deletion of Ncstn in an acne inversa-like mouse model leads to a markedly increased IL-36a and Sprr2 expression
Jun Yang et al.
FRONTIERS OF MEDICINE (2020)
Emerging medical treatments for hidradenitis suppurativa
Alexis B. Lyons et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Profile of smoking dependency in hidradenitis suppurativa patients and smoking cessation outcomes
F. Deilhes et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Ultrasound: an indispensable tool to evaluate the outcome of surgical approaches in patients affected by hidradenitis suppurativa
C. Marasca et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
The pharmacology of antibiotic therapy in hidradenitis suppurativa
Claudio Marasca et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2020)
Hidradenitis suppurativa
Robert Sabat et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Emerging drugs for the treatment of hidradenitis suppurativa
Alecia S. Folkes et al.
EXPERT OPINION ON EMERGING DRUGS (2020)
Aetiology and pathogenesis of hidradenitis suppurativa
K. Wolk et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Sebaceous gland: Milestones of 30-year modelling research dedicated to the brain of the skin
Christos C. Zouboulis et al.
EXPERIMENTAL DERMATOLOGY (2020)
New insights into mechanism of Notch signaling in hidradenitis suppurativa
Emanuele Scala et al.
GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA (2020)
Contribution of Genetics to the Susceptibility to Hidradenitis Suppurativa in a Large, Cross-Sectional Dutch Twin Cohort
Kelsey R. van Straalen et al.
JAMA DERMATOLOGY (2020)
Dysregulation of tryptophan catabolism at the host-skin microbiota interface in hidradenitis suppurativa
Laure Guenin-Mace et al.
JCI INSIGHT (2020)
Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa
Ester Del Duca et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
HIDRAdisk: an innovative visual tool to assess the burden of hidradenitis suppurativa
A. Chiricozzi et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Anti-TNF-α therapy modulates mTORC1 signalling in hidradenitis suppurativa
A. Balato et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group
C. C. Zouboulis et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Hidradenitis suppurativa and diabetes mellitus: updated systematic review and adjusted meta-analysis
K. Phan et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2019)
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part II: Topical, intralesional, and systemic medical management
Ali Alikhan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26
E. Scala et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials
G. B. E. Jemec et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Ex vivo human models of hidradenitis suppurativa/acne inversa for laboratory research and drug screening
C. C. Zouboulis
BRITISH JOURNAL OF DERMATOLOGY (2019)
Severity staging of hidradenitis suppurativa: is Hurley classification the answer?
L. Thorlacius
BRITISH JOURNAL OF DERMATOLOGY (2019)
An Integrated Approach to Unravel Hidradenitis Suppurativa Etiopathogenesis
Paola M. Tricarico et al.
FRONTIERS IN IMMUNOLOGY (2019)
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients
G. Fabbrocini et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study
A. R. J. V. Vossen et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Hidradenitis suppurativa of the nape: Description of an atypical phenotype related to severe early-onset disease in men
Eugenia Agut-Busquet et al.
JOURNAL OF DERMATOLOGY (2019)
The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction
Ellen Witte-Haendel et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Insulin resistance, mTOR and hidradenitis suppurativa
C. Marasca et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Rates of antibiotic resistance/sensitivity in bacterial cultures of hidradenitis suppurativa patients
V. Bettoli et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
IL-26, a Cytokine With Roles in Extracellular DNA-Induced Inflammation and Microbial Defense
Vincent Larochette et al.
FRONTIERS IN IMMUNOLOGY (2019)
Development and Preliminary Validation of the HSQoL-24 Tool to Assess Quality of Life in Patients With Hidradenitis Suppurativa
S. E. Marron et al.
ACTAS DERMO-SIFILIOGRAFICAS (2019)
Hidradenitis suppurativa: infection, autoimmunity, or both?
Costas A. Constantinou et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2019)
Inherent differences in keratinocyte function in hidradenitis suppurativa: Evidence for the role of IL-22 in disease pathogenesis
Derek Jones et al.
IMMUNOLOGICAL INVESTIGATIONS (2018)
Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa
Alexa B. Kimball et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2018)
Research Techniques Made Simple: Murine Models of Human Psoriasis
Jason E. Hawkes et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Acne and hidradenitis suppurativa
A. Pink et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Adipokines are dysregulated in patients with hidradenitis suppurativa
A. Malara et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Allison Agus et al.
CELL HOST & MICROBE (2018)
Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa
Taylor L. Braunberger et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2018)
Hidradenitis suppurativa and diabetes mellitus: A systematic review and meta-analysis
Thanh-Lan Bui et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States
Amit Garg et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Association of Hidradenitis Suppurativa With Body Image
Sylke Schneider-Burrus et al.
JAMA DERMATOLOGY (2018)
A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa
Schapoor Hessam et al.
JAMA DERMATOLOGY (2018)
Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa
S. Hessam et al.
INFLAMMATION (2017)
The critical role of macrophages in the pathogenesis of hidradenitis suppurativa
Ahmed Shah et al.
INFLAMMATION RESEARCH (2017)
Hidradenitis Suppurativa Advances in Diagnosis and Treatment
Ditte Marie Lindhardt Saunte et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Interleukin 6 and high-sensitivity C-reactive protein are potential predictive markers of response to infliximab in hidradenitis suppurativa
Henri Montaudie et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
The role of wide local excision for the treatment of severe hidradenitis suppurativa (Hurley grade III): Retrospective analysis of 74 patients
Christian Posch et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Organ-on-Chip Technology: Current State and Future Developments
Rimantas Kodzius et al.
GENES (2017)
Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity
C. C. Zouboulis et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
IL-36 cytokines are increased in acne and hidradenitis suppurativa
Roberta Di Caprio et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2017)
The Microbiological Landscape of Anaerobic Infections in Hidradenitis Suppurativa: A Prospective Metagenomic Study
Helene Guet-Revillet et al.
CLINICAL INFECTIOUS DISEASES (2017)
Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment
Maddalena Napolitano et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2017)
Bacterial biofilm in chronic lesions of hidradenitis suppurativa
H. C. Ring et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Overweight, diabetes and disease duration influence clinical severity in hidradenitis suppurativa-acne inversa: evidence from the national Italian registry
V. Bettoli et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
mTORC1 signaling and IL-17 expression: Defining pathways and possible therapeutic targets
Wenkai Ren et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients
Olivier Join-Lambert et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Mammalian target of rapamycin, insulin resistance and hidradenitis suppurativa: a possible metabolic loop
G. Monfrecola et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study
A. B. Kimball et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality
J. R. Ingram et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum
J. L. Blok et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Diagnosing Hidradenitis Suppurativa
Jean E. Revuz et al.
DERMATOLOGIC CLINICS (2016)
Inflammatory Mechanisms in Hidradenitis Suppurativa
G. Kelly et al.
DERMATOLOGIC CLINICS (2016)
The ABC of Hidradenitis Suppurativa: A Validated Glossary on how to Name Lesions
Dan Lipsker et al.
DERMATOLOGY (2016)
Intrinsic Defect in Keratinocyte Function Leads to Inflammation in Hidradenitis Suppurativa
Claire Hotz et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
The Hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities
V. Bettoli et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Alexa B. Kimball et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients
G. Shalom et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa
Alex Anstey
BRITISH JOURNAL OF DERMATOLOGY (2015)
The roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infections
Amy E. Bryant et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2015)
Animal Models for Alopecia Areata: What and Where?
John P. Sundberg et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2015)
Pain management in patients with hidradenitis suppurativa
Barbara Horvath et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes
Hessel H. van der Zee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
C. C. Zouboulis et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
The Hidradenitis Suppurativa Priority Setting Partnership
J. R. Ingram et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities
J. J. Crowley et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
A novel NCSTN mutation alone may be insufficient for the development of familial hidradenitis suppurativa
Yukiko Nomura et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2014)
Bacterial Pathogens Associated with Hidradenitis Suppurativa, France
Helene Guet-Revillet et al.
EMERGING INFECTIOUS DISEASES (2014)
Absence of pathogenic γ-secretase mutations in a South Wales cohort of familial and sporadic hidradenitis suppurativa (acne inversa)
J. R. Ingram et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Ultrasound In-Depth Characterization and Staging of Hidradenitis Suppurativa
Ximena Wortsman et al.
DERMATOLOGIC SURGERY (2013)
Identification of Three Hidradenitis Suppurativa Phenotypes: Latent Class Analysis of a Cross-Sectional Study
Florence Canoui-Poitrine et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells
Solenne Vigne et al.
BLOOD (2012)
Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study
H. H. van der Zee et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Can Animal Skin Diseases or Current Transgenic Mice Serve as a Model for Hidradenitis Suppurativa?
H. H. van der Zee et al.
DERMATOLOGY (2012)
Mutations in the γ-Secretase Genes NCSTN, PSENEN, and PSEN1 Underlie Rare Forms of Hidradenitis Suppurativa (Acne Inversa)
Andrew E. Pink et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β
H. H. van der Zee et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Efficacy of Rifampin-Moxifloxacin-Metronidazole Combination Therapy in Hidradenitis Suppurativa
Olivier Join-Lambert et al.
DERMATOLOGY (2011)
Dapsone Therapy for Hidradenitis Suppurativa: A Series of 24 Patients
Shiva Yazdanyar et al.
DERMATOLOGY (2011)
Deficiency of IL-22 Contributes to a Chronic Inflammatory Disease: Pathogenetic Mechanisms in Acne Inversa
Kerstin Wolk et al.
JOURNAL OF IMMUNOLOGY (2011)
Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa
Christoph Schlapbach et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Interobserver variability of clinical scores in hidradenitis suppurativa is low
K. Sartorius et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions
S. Esmann et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis*
Maximilian von Laffert et al.
EXPERIMENTAL DERMATOLOGY (2010)
Deroofing: A tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions
Hessel H. van der Zee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
γ-Secretase Gene Mutations in Familial Acne Inversa
Baoxi Wang et al.
SCIENCE (2010)
Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity
K. Sartorius et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Combination Therapy with Clindamycin and Rifampicin for Hidradenitis Suppurativa: A Series of 116 Consecutive Patients
G. Gener et al.
DERMATOLOGY (2009)
Hidradenitis suppurativa
J. Revuz
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies
Jean E. Revuz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Inversa acne (Hidradenitis suppurativa): A case report and identification of the locus at chromosome 1p21.1-1q25.3
Min Gao et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Treatment of recalcitrant hidradenitis suppurativa with oral ciclosporin
RF Rose et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2006)
Interleukin-12-induced interferon-γ production by human peripheral blood T cells is regulated by mammalian target of rapamycin (mTOR)
H Kusaba et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Interferon-γ:: an overview of signals, mechanisms and functions
K Schroder et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
The clinical genetics of hidradenitis suppurativa revisited
JM Von der Werth et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
Share Paper
